Low serum pseudocholinesterase levels complicating treatment with phenelzine.
Four patients undergoing treatment with phenelzine developed low serum pseudocholinesterase levels. In one of the patients an apnoea of one hour followed modified electric convulsion therapy. In three cases investigations showed that the serum pseudocholinesterase levels returned to normal after withdrawal of phenelzine.
D000328:Adult; D001049:Apnea / Q000139:chemically induced; D002802:Cholinesterases / Q000097:blood*; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D010624:Phenelzine / Q000009:adverse effects*; D013390:Succinylcholine / Q000009:adverse effects
D002802:Cholinesterases; D013390:Succinylcholine; D010624:Phenelzine